Gottfried Hirnschall

Towards an improved investment approach for an effective response to HIV/AIDS

Bernhard Schwartländer, John Stover, Timothy B. Hallett et al. · The Lancet · 2011 · 528 citations

Public Health, Health Policy, Infectious Disease Control +14

Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models

Jeffrey W. Eaton, Nicolas A. Menzies, John Stover et al. · The Lancet Global Health · 2013 · 246 citations · Full text

Pharmacy, Health Policy, Pharmacoeconomics +17

Additional resource needs for viral hepatitis elimination through universal health coverage: projections in 67 low-income and middle-income countries, 2016–30

David Tordrup, Yvan Hutin, Karin Stenberg et al. · The Lancet Global Health · 2019 · 99 citations · Full text

Public Affairs, Health Policy, Pharmacoeconomics +17

A global investment framework for the elimination of hepatitis B

Jessica Howell, Alisa Pedrana, Sophia Schroeder et al. · Journal of Hepatology · 2020 · 96 citations · Full text

Public Affairs, Health Policy, Infectious Diseases +14

Linking the integrated management of childhood illness (IMCI) and health information system (HIS) classifications: issues and options.

Alexander K. Rowe, Gottfried Hirnschall, Thierry Lambrechts et al. · PubMed · 1999 · 88 citations

Public Health, Health Care Management, Disease Surveillance +12